Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMLA cream taping technique for pain reduction during pretarsal botulinum toxin A injection in hemifacial spasm
TCTR20240913006Phase 2Unknown
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Sep 2024
- Modality
- Small Molecules, Drug Delivery Systems, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of lidocaine + prilocaine and botulinum toxin type A in hemifacial spasm (HFS) (2 arms), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Primary endpoint: Pain score. Status: unknown.
02
Drugs
lidocaine + prilocainebotulinum toxin type A
03
Conditions
hemifacial spasm (HFS)
Beyond the preview
Go deeper on TCTR20240913006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240913006.